Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
2011; Oxford University Press; Volume: 52; Issue: 11 Linguagem: Inglês
10.1093/cid/cir230
ISSN1537-6591
AutoresM. Estée Török, N. T. B. Yen, Ha Vinh, N. T. H., N. H. Phu, P. P., Nguyễn Thị Dung, Nguyen VV Chau, N D Bang, Tien Anh Nguyen, Nguyen Hien Minh, Nguyen Quang Hien, P. V. K. Thai, Danfeng Dong, D. T. T. Anh, Nguyen Thi Cam Thoa, Nguyễn Ngọc Hải, Ngoc‐Lan Nguyen, Nguyễn Thị Ngọc Lan, Hoang Thi Quy, Nguyen Huy Dung, T T Hien, N.T. Chinh, Cameron P. Simmons, Marion de Jong, Marcel Wolbers, Jeremy Farrar,
Tópico(s)Bacterial Infections and Vaccines
ResumoBackground. The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)–associated tuberculous meningitis is unknown.
Referência(s)